Synergistic actions of FGF2 and bone marrow transplantation mitigate radiation-induced intestinal injury

Unwanted radiological or nuclear exposure remains a public health risk for which effective therapeutic countermeasures are lacking. Here, we evaluated the efficacy of fibroblast growth factor-2 (FGF2) in treating radiation-induced gastrointestinal syndrome (RIGS) incurred by lethal whole-body irradi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Byoung Hyuck, Jung, Hee-Won, Seo, Seok Hyun, Shin, Hyemi, Kwon, Jeanny, Suh, Jae Myoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841425/
https://www.ncbi.nlm.nih.gov/pubmed/29515101
http://dx.doi.org/10.1038/s41419-018-0421-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841425/
https://www.ncbi.nlm.nih.gov/pubmed/29515101
http://dx.doi.org/10.1038/s41419-018-0421-4

Ejemplares similares